Plasma isoflavones and the risk of lung cancer in women: A nested case-control study in Japan

Cancer Epidemiology Biomarkers and Prevention

Volumn 20, Issue 3, 2011, Pages 419-427

  Shimazu, Taichi ^a   Inoue, Manami ^a   Sasazuki, Shizuka ^a   Iwasaki, Motoki ^a   Sawada, Norie ^a   Yamaji, Taiki ^a   Tsugane, Shoichiro ^a  

^a NATIONAL CANCER CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DAIDZEIN; EQUOL; GENISTEIN; GLYCITEIN; ISOFLAVONE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER RISK; CASE CONTROL STUDY; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; FOLLOW UP; FOOD INTAKE; HEALTH SURVEY; HUMAN; JAPAN; LUNG CANCER; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE;

ADULT; AGED; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; GENISTEIN; HUMANS; ISOFLAVONES; JAPAN; LUNG NEOPLASMS; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 79955773946     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-10-1025     Document Type: Article

References (45)

1. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, Van Der Saag PT, et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998;139:4252-63. (Pubitemid 28513713)
2. Bingham SA, Atkinson C, Liggins J, Bluck L, Coward A. Phyto-oestrogens: where are we now? Br J Nutr 1998;79:393-406.
3. Yamamoto S, Sobue T, Kobayashi M, Sasaki S, Tsugane S. Soy, isoflavones, and breast cancer risk in Japan. J Natl Cancer Inst 2003;95:906-13. (Pubitemid 36833882)
4. Wu AH, Yu MC, Tseng CC, Pike MC. Epidemiology of soy exposures and breast cancer risk. Br J Cancer 2008;98:9-14.
5. Iwasaki M, Inoue M, Otani T, Sasazuki S, Kurahashi N, Miura T, et al. Plasma isoflavone level and subsequent risk of breast cancer among Japanese women: a nested case-control study from the Japan Public Health Center-based prospective study group. J Clin Oncol 2008;26:1677-83.
6. Yan L, Spitznagel EL. Soy consumption and prostate cancer risk in men: a revisit of a meta-analysis. Am J Clin Nutr 2009;89:1155-63.
7. Kurahashi N, Iwasaki M, Sasazuki S, Otani T, Inoue M, Tsugane S. Soy product and isoflavone consumption in relation to prostate cancer in Japanese men. Cancer Epidemiol Biomarkers Prev 2007;16:538-45. (Pubitemid 46548658)
8. Kurahashi N, Iwasaki M, Inoue M, Sasazuki S, Tsugane S. Plasma isoflavones and subsequent risk of prostate cancer in a nested case-control study: the Japan Public Health Center. J Clin Oncol 2008;26:5923-9.
9. Siegfried JM. Women and lung cancer: does oestrogen play a role?Lancet Oncol 2001;2:506-13.
10. Fasco MJ, Hurteau GJ, Spivack SD. Gender-dependent expression of alpha and beta estrogen receptors in human nontumor and tumor lung tissue. Mol Cell Endocrinol 2002;188:125-40. (Pubitemid 34242672)
11. Mollerup S, Jorgensen K, Berge G, Haugen A. Expression of estrogen receptors alpha and beta in human lung tissue and cell lines. Lung Cancer 2002;37:153-9. (Pubitemid 34831807)
12. Chlebowski RT, Schwartz AG, Wakelee H, Anderson GL, Stefanick ML, Manson JE, et al. Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial. Lancet 2009;374:1243-51.
13. Hulley S, Furberg C, Barrett-Connor E, Cauley J, Grady D, Haskell W, et al. Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA 2002;288:58-66. (Pubitemid 34705519)
14. Lian F, Bhuiyan M, Li YW, Wall N, Kraut M, Sarkar FH. Genistein-induced G2-M arrest, p21WAF1 upregulation, and apoptosis in a non-small-cell lung cancer cell line. Nutr Cancer 1998;31:184-91. (Pubitemid 28481852)
15. Gallo D, Zannoni GF, De Stefano I, Mosca M, Ferlini C, Mantuano E, et al. Soy phytochemicals decrease nonsmall cell lung cancer growth in female athymic mice. J Nutr 2008;138:1360-4. (Pubitemid 351931003)
16. Gadgeel SM, Ali S, Philip PA, Wozniak A, Sarkar FH. Genistein enhances the effect of epidermal growth factor receptor tyrosine kinase inhibitors and inhibits nuclear factor kappa B in nonsmall cell lung cancer cell lines. Cancer 2009;115:2165-76.
17. Schabath MB, Hernandez LM, Wu X, Pillow PC, Spitz MR. Dietary phytoestrogens and lung cancer risk. JAMA 2005;294:1493-504. (Pubitemid 41362686)
18. Cutler GJ, Nettleton JA, Ross JA, Harnack LJ, Jacobs DR Jr., Scrafford CG, et al. Dietary flavonoid intake and risk of cancer in post-menopausal women: the Iowa Women's Health Study. Int J Cancer 2008;123:664-71. (Pubitemid 351898426)
19. Seow A, Koh WP, Wang R, Lee HP, Yu MC. Reproductive variables, soy intake, and lung cancer risk among nonsmoking women in the Singapore Chinese Health Study. Cancer Epidemiol Biomarkers Prev 2009;18:821-7.
20. Shimazu T, Inoue M, Sasazuki S, Iwasaki M, Sawada N, Yamaji T, et al. Isoflavone intake and risk of lung cancer: a prospective cohort study in Japan. Am J Clin Nutr 2010;91:722-8.
21. Bowey E, Adlercreutz H, Rowland I. Metabolism of isoflavones and lignans by the gut microflora: a study in germ-free and human flora associated rats. Food Chem Toxicol 2003;41:631-6. (Pubitemid 36349543)
22. Atkinson C, Frankenfeld CL, Lampe JW. Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health. Exp Biol Med (Maywood) 2005;230:155-70. (Pubitemid 40293689)
23. Sobue T, Yamamoto S, Hara M, Sasazuki S, Sasaki S, Tsugane S. Cigarette smoking and subsequent risk of lung cancer by histologic type in middle-aged Japanese men and women: the JPHC study. Int J Cancer 2002;99:245-51. (Pubitemid 34309482)
24. Tsugane S, Sobue T. Baseline survey of JPHC study-design and participation rate. Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases. J Epidemiol 2001;11:S24-9.
25. Ministry of Education Culture Sports Science and Technology / Ministry of Health Labour and Welfare. Ethical guidelines for epidemiological research (in Japanese). 2008[cited 2010 November 24]; Available from: http://www.mhlw.go.jp/ general/seido/kousei/i-kenkyu/#2
26. Tsubono Y, Otani T, Kobayashi M, Yamamoto S, Sobue T, Tsugane S. No association between fruit or vegetable consumption and the risk of colorectal cancer in Japan. Br J Cancer 2005;92:1782-4. (Pubitemid 40756492)
27. Kobayashi M, Tsubono Y, Otani T, Hanaoka T, Sobue T, Tsugane S. Fish, long-chain n-3 polyunsaturated fatty acids, and risk of colorectal cancer in middle-aged Japanese: the JPHC study. Nutr Cancer 2004;49:32-40. (Pubitemid 39299124)
28. Tsubono Y, Kobayashi M, Sasaki S, Tsugane S. Validity and reproducibility of a self-administered food frequency questionnaire used in the baseline survey of the JPHC Study Cohort I. J Epidemiol 2003;13:S125-33.
29. World Health Organization. International classification of diseases for oncology. Third Edition. 3rd ed. Geneva: WHO; 2000.
30. Travis WD, Colby TV, Corrin B, Shimosato Y, Brambilla E. Histological typing of lung and pleural tumours. 3rd ed. Berlin: Springer; 1999.
31. Coward L, Kirk M, Albin N, Barnes S. Analysis of plasma isoflavones by reversed-phase HPLC-multiple reaction ion monitoring-mass spectrometry. Clin Chim Acta 1996;247:121-42. (Pubitemid 26103162)
32. Mantel N. Chi-square tests with one degree of freedom; extensions of the Mantel-Haenszel procedure. J Am Stat Assoc 1963;58:690-700.
33. SAS Institute. SAS/STAT 9.1 user's guide, volumes 1-7. Cary, NC: SAS Institute; 2004.
34. Coldham NG, Dave M, Sivapathasundaram S, McDonnell DP, Connor C, Sauer MJ. Evaluation of a recombinant yeast cell estrogen screening assay. Environmental health perspectives 1997;105:734-42. (Pubitemid 27450334)
35. Matsumura A, Ghosh A, Pope GS, Darbre PD. Comparative study of oestrogenic properties of eight phytoestrogens in MCF7 human breast cancer cells. J Steroid Biochem Mol Biol 2005;94:431-43. (Pubitemid 40616404)
36. Breinholt V, Larsen JC. Detection of weak estrogenic flavonoids using a recombinant yeast strain and a modified MCF7 cell proliferation assay. Chem Res Toxicol 1998;11:622-9. (Pubitemid 28285587)
37. Sun S, Schiller JH, Gazdar AF. Lung cancer in never smokers-a different disease. Nat Rev Cancer 2007;7:778-90. (Pubitemid 47463669)
38. Sordella R, Bell DW, Haber DA, Settleman J. Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways. Science 2004;305:1163-7. (Pubitemid 39100331)
39. Maemondo M, Inoue A, Kobayashi K, Sugawara S, Oizumi S, Isobe H, et al. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR. N Engl J Med 2010;362:2380-8.
40. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, et al. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 1987;262:5592-5.
41. Matsuo K, Hiraki A, Ito H, Kosaka T, Suzuki T, Hirose K, et al. Soy consumption reduces the risk of non-small-cell lung cancers with epidermal growth factor receptor mutations among Japanese. Cancer Sci 2008;99:1202-8. (Pubitemid 351676633)
42. Shigematsu H, Gazdar AF. Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers. Int J Cancer 2006;118:257-62. (Pubitemid 41779062)
43. Yamamoto S, Sobue T, Sasaki S, Kobayashi M, Arai Y, Uehara M, et al. Validity and reproducibility of a self-administered food-frequency questionnaire to assess isoflavone intake in a japanese population in comparison with dietary records and blood and urine isoflavones. J Nutr 2001;131:2741-7. (Pubitemid 32947803)
44. Nielsen IL, Williamson G. Review of the factors affecting bioavailability of soy isoflavones in humans. Nutr Cancer 2007;57:1-10. (Pubitemid 46871564)
45. Iwasaki M, Otani T, Yamamoto S, Inoue M, Hanaoka T, Sobue T, et al. Background characteristics of basic health examination participants: the JPHC Study Baseline Survey. J Epidemiol 2003;13:216-25. (Pubitemid 44130745)